Organon & Co (United States) is listed on the Nasdaq and has a market capitalization of $2.54 Billions, with shareholders equity totaling $906.00 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Organon & Co reported $4.62 Billions in revenue, generating net income of $-44.77 Millions.
Key financial metrics include a P/E ratio of -56.72, a price-to-book (P/B) ratio of 2.80, and a trailing twelve-month dividend yield of 0.82%.
The company trades under the ticker OGN.